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Background
Hemochromatosis (HH) is a disease where the intestinal
absorption of iron is high and multi-organ iron overload
may result with organ failure. Dilated cardiomyopathy in
this condition is considered a consequence of cardiac
siderosis, but there is contradictory evidence for this. Car-
diovascular Magnetic Resonance (CMR) detects iron dep-
osition in the liver and in the heart with the T2*
technique. Several studies have confirmed the normal
range of iron in the liver and heart for normal subjects and
the abnormal value above which heart failure is a com-
mon risk. T2* is also useful to follow the chelation treat-
ment of these patients and recent medical trials have
confirmed the utility of deferiprone and deferoxamine to
reduce the heart iron overload and increase the left ventri-
cle systolic function in patients with thalassaemia. How-
ever, while the direct link between cardiac siderosis and
dilated cardiomyopathy is confirmed in thalassaemia, in
HH the correlation between heart iron overload and
dilated cardiomyopathy requires further investigation. In
this study, we hypothesized the existence of a direct rela-
tionship between myocardial iron deposition and dilated
cardiomyopathy in HH.
Methods
We retrospectively analyzed 1016 consecutive patients
presenting for the evaluation of myocardial and liver iron
overload from 1996 to 2006. All these patients had a con-
firmed diagnosis and were followed by specialized centers
across the UK. Of this cohort, 53 patients had HH.
Patients underwent cardiovascular magnetic resonance at
1.5 T (Siemens Sonata or Avanto, Erlangen, Germany).
Each scan included the measurement of liver and heart
T2*, and left and right ventricular function, volumes and
mass using standard techniques with analysis using CMR-
tools (Cardiovascular Imaging Solutions, London).
Results
The CMR characteristic (LV volumes, T2* of liver and
heart) of the patients are shown in Table 1. The age of the
patients varied from 36 to 76 years. All patients were on
medical treatment appropriate to the presenting symp-
toms from their HH.
Figure 1 shows the scatterplot of myocardial T2* against
LV EF. Six patients (11%) had myocardial iron loading,
and of these, 3 had (50%) significant LV dysfunction (EF
< 56%). A further 5 patients had impaired LV function
with normal myocardial T2* values, and of these 4 (80%)
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Table 1: 
LVEDV LVESV LVEF LV mass Liver T2* Cardiac T2*
Mean 95% CI 152 mL (138, 166) 58.5 mL (44.7, 72.2) 65.0% (60.7, 69.2) 151 g (138, 165) 11.3 ms (8.3, 4.2) 30.0 ms (26.6, 33.6)Page 1 of 2
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had an alternative explanation for the dysfunction (2
patients with previous anterior infarction, 1 with previ-
ously diagnosed idiopathic dilated cardiomyopathy, and
1 with arrhythmia).
Conclusion
These findings suggest that in patients with HH, cardiac
siderosis is a relatively uncommon complication (11%),
which directly results in impaired LV function cardiomy-
opathy in half of these cases (6%).
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